Skip to main content
Figure 5 | Critical Care

Figure 5

From: Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolism

Figure 5

Sekisui soluble fibrin, TINAquant D-dimer, and Iatron FDP-P at end of study drug infusion. Sekisui soluble fibrin, Tinaquant D-dimer, and Iatron FDP-P: comparison of the results of the 12-hour sample for all patients with an initial TINAquant D-dimer level of >4 mg/L Patients receiving DAA displayed significantly lower levels of fibrin-related markers at the end of the study drug infusion.

Back to article page

Critical Care

ISSN: 1364-8535